
Pharmacally
Arlo-Cel
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Arlo-Cel
Clinical TrialsArlo-cel Shows Strong Results in Hard-to-Treat Multiple MyelomaBristol Myers Squibb reported positive topline results from the registrational Phase 2 QUINTESSENTIAL trial evaluating arlocabtagene autoleucel (arlo-cel; BMS-986393) in patients with quadruple-class exposed relapsed and refractory multiple…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.